IW
WST icon

Imprint Wealth’s West Pharmaceutical WST Stock Holding History

Imprint Wealth’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.01K Hold
12
– – 0.01% 206
2025
Q4 		$3.3K Sell
12
-28
-70% -$7.66K 0.02% 228
2025
Q3 		$10.5K Buy
+40
New +$9.72K 0.03% 193

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Imprint Wealth's WST Position: Q1 2026 in Review

Imprint Wealth held its West Pharmaceutical (WST) position steady in Q1 2026 at 12 shares worth $3.01K. The position accounts for 0.01% of the portfolio, ranked #206.

Imprint Wealth first reported a position in WST in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.5K in Q3 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Imprint Wealth held 12 shares of West Pharmaceutical worth $3.01K as of Q1 2026.
  • Imprint Wealth left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up 0.01% of Imprint Wealth's portfolio in Q1 2026, its #206 holding.
  • Imprint Wealth first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Imprint Wealth's West Pharmaceutical position peaked at $10.5K in Q3 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Imprint Wealth's 13F filing for Q1 2026, filed 15 May 2026.